Literature DB >> 6684520

Relationship between local and total body bone mineral in epileptic patients and normal subjects.

L Tjellesen, A Gotfredsen, J Borg, C Christiansen.   

Abstract

Total body bone mineral (TBBM), measured by dual photon absorptiometry, and local body bone mineral content (BMC), measured by single photon absorptiometry, in both forearms were determined in 49 epileptic patients, 19 receiving phenytoin and 30 receiving carbamazepine, and in 55 controls. A highly significant correlation was found between BMC and TBBM in the patients (r = 0.81, SEE = 10.6%), as well as in the controls (r = 0.78, SEE = 9.9%). Furthermore, the intercepts and the slopes were virtually of the same order. The patients on phenytoin had a mild generalised osteomalacia, independent of method used, whereas the patients on carbamazepine did not have this side-effect. It is concluded that BMC of the forearm can be used as a valid estimate of total body bone mineral in groups of epileptic patients and in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684520     DOI: 10.1111/j.1475-097x.1983.tb00718.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  4 in total

1.  Bone changes occurring spontaneously and caused by estrogen in early postmenopausal women: a local or generalised phenomenon?

Authors:  A Gotfredsen; L Nilas; B J Riis; K Thomsen; C Christiansen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

2.  New methods for identifying "at risk" patients for osteoporosis.

Authors:  C Christiansen; B J Riis
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

3.  Relationship between local and total bone mineral in normal pubertal boys.

Authors:  S Krabbe; A Gotfredsen; C Christiansen
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183

Review 4.  Treating epilepsy in the elderly: safety considerations.

Authors:  S Arroyo; G Kramer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.